1. Home
  2. IRWD vs HBNC Comparison

IRWD vs HBNC Comparison

Compare IRWD & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • HBNC
  • Stock Information
  • Founded
  • IRWD 1998
  • HBNC 1873
  • Country
  • IRWD United States
  • HBNC United States
  • Employees
  • IRWD N/A
  • HBNC N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • HBNC Major Banks
  • Sector
  • IRWD Health Care
  • HBNC Finance
  • Exchange
  • IRWD Nasdaq
  • HBNC Nasdaq
  • Market Cap
  • IRWD 716.9M
  • HBNC 648.7M
  • IPO Year
  • IRWD 2010
  • HBNC N/A
  • Fundamental
  • Price
  • IRWD $4.21
  • HBNC $18.29
  • Analyst Decision
  • IRWD Buy
  • HBNC Hold
  • Analyst Count
  • IRWD 4
  • HBNC 3
  • Target Price
  • IRWD $12.00
  • HBNC $15.33
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • HBNC 173.4K
  • Earning Date
  • IRWD 11-07-2024
  • HBNC 10-23-2024
  • Dividend Yield
  • IRWD N/A
  • HBNC 3.50%
  • EPS Growth
  • IRWD N/A
  • HBNC N/A
  • EPS
  • IRWD N/A
  • HBNC 0.48
  • Revenue
  • IRWD $378,418,000.00
  • HBNC $183,718,000.00
  • Revenue This Year
  • IRWD N/A
  • HBNC N/A
  • Revenue Next Year
  • IRWD N/A
  • HBNC $13.00
  • P/E Ratio
  • IRWD N/A
  • HBNC $37.83
  • Revenue Growth
  • IRWD N/A
  • HBNC N/A
  • 52 Week Low
  • IRWD $3.79
  • HBNC $10.65
  • 52 Week High
  • IRWD $15.70
  • HBNC $18.86
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 46.85
  • HBNC 69.60
  • Support Level
  • IRWD $4.26
  • HBNC $18.30
  • Resistance Level
  • IRWD $5.07
  • HBNC $18.86
  • Average True Range (ATR)
  • IRWD 0.32
  • HBNC 0.49
  • MACD
  • IRWD -0.02
  • HBNC 0.19
  • Stochastic Oscillator
  • IRWD 24.56
  • HBNC 91.11

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

Share on Social Networks: